Nurix Therapeutics, Inc. (NRIX)

CIK 1549595 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nurix Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 202640001817199-26-000030
Sep 2, 20261440001950047-26-009016
Sep 1, 202640001817160-26-000019
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097194
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003499
Aug 14, 2026SCHEDULE 13G0001104659-26-097100
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003488
Aug 14, 2026SCHEDULE 13G0000080255-26-000570
Aug 5, 202640001817160-26-000017
Aug 5, 202640001817160-26-000015
Aug 5, 20261440001950047-26-007704
Aug 4, 20261440001950047-26-007639
Aug 4, 202640001817217-26-000012
Aug 4, 20261440001950047-26-007637
Aug 3, 202640001817199-26-000028
Aug 3, 20261440001950047-26-007550
Jul 31, 2026SCHEDULE 13G0002100119-26-001437
Jul 30, 202640001817217-26-000010
Jul 30, 202640001817199-26-000026
Jul 30, 202640001817160-26-000012
Jul 9, 20268-K0001549595-26-000038
Jul 9, 202610-Q0001549595-26-000040
Jul 2, 202640001817199-26-000024
Jul 2, 20261440001950047-26-006819
Jun 25, 20261440001950047-26-006499